Epigenetic Modifications and Potential New Treatment Targets in Diabetic Retinopathy

Perrone, L., Matrone, C., & Singh, L. P. (2014). Erratum to ＂Epigenetic Modifications and Potential New Treatment Targets in Diabetic Retinopathy＂. Journal of Ophthalmology, (2014-4), 45-45. https://doi.org/10.1155/2014/836450
謝瑞玟、陳立仁、韋熙（2003）。Managed Care for Diabetic Patients: Evaluation of Screening Pathway of Diabetic Retinopathy。中華民國眼科醫學會雜誌，42(4)，404-414。https://doi.org/10.30048/ACTASOS.200312.0003
Yang, M. M., Wang, J., Ren, H., Sun, U., Fan, J. J., Teng, Y., & Li, Y. B. (2016). Genetic Investigation of Complement Pathway Genes in Type 2 Diabetic Retinopathy: An Inflammatory Perspective. Mediators of Inflammation, 2016(), 71-77-006. https://doi.org/10.1155/2016/1313027
游建章（2010）。Clinical and Basic Research of the Angiogenic Factors in Proliferative Diabetic Retinopathy〔博士論文，國立臺灣大學〕。華藝線上圖書館。https://doi.org/10.6342/NTU.2010.03320
Zorena, K. (2014). Anti-Inflammatory Therapy in Diabetic Retinopathy. Mediators of Inflammation, (2014-9), 393-394. https://doi.org/10.1155/2014/947896